Skip to content
healthcare.dev

ZALEPLON

NDC 65862-214, ZALEPLON, capsule, from Aurobindo Pharma Limited.

Product NDC
65862-214
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078829
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-214 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZALEPLON5 mg/1

Pharmacologic classes

Central Nervous System Depression [PE]; GABA A Agonists [MoA]; gamma-Aminobutyric Acid A Receptor Agonist [EPC]

Package NDCNDC-11Package
65862-214-0165862021401100 CAPSULE in 1 BOTTLE (65862-214-01)
65862-214-0565862021405500 CAPSULE in 1 BOTTLE (65862-214-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e092f3ca-bf44-4568-a72c-3fb2cf5b192b
  • NADAC price for package 65862021401

    GET /v1/drugs/nadac/65862021401

Use it

Look up 65862-214 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-214 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-214. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.